ATE367445T1 - Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen - Google Patents
Viraler paramyxoviridae vektor mit einem defekten hüllprotein-genInfo
- Publication number
- ATE367445T1 ATE367445T1 AT00927807T AT00927807T ATE367445T1 AT E367445 T1 ATE367445 T1 AT E367445T1 AT 00927807 T AT00927807 T AT 00927807T AT 00927807 T AT00927807 T AT 00927807T AT E367445 T1 ATE367445 T1 AT E367445T1
- Authority
- AT
- Austria
- Prior art keywords
- gene
- deficient
- virus
- paramyxoviridae
- successfully
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18841—Use of virus, viral particle or viral elements as a vector
- C12N2760/18845—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18811—Sendai virus
- C12N2760/18861—Methods of inactivation or attenuation
- C12N2760/18862—Methods of inactivation or attenuation by genetic engineering
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
- C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6072—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses
- C12N2810/6081—Vectors comprising as targeting moiety peptide derived from defined protein from viruses negative strand RNA viruses rhabdoviridae, e.g. VSV
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20073999 | 1999-05-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE367445T1 true ATE367445T1 (de) | 2007-08-15 |
Family
ID=16429375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00927807T ATE367445T1 (de) | 1999-05-18 | 2000-05-18 | Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1186667B1 (de) |
JP (2) | JP3602058B2 (de) |
KR (2) | KR100739938B1 (de) |
CN (1) | CN1330767C (de) |
AT (1) | ATE367445T1 (de) |
AU (1) | AU4614600A (de) |
CA (1) | CA2368948C (de) |
DE (1) | DE60035589T2 (de) |
DK (1) | DK1186667T3 (de) |
ES (1) | ES2288473T3 (de) |
HK (1) | HK1044352A1 (de) |
WO (1) | WO2000070070A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7241617B2 (en) | 1998-07-03 | 2007-07-10 | Dnavec Research, Inc. | Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci |
WO2000001837A1 (fr) * | 1998-07-03 | 2000-01-13 | Dnavec Research Inc. | Vecteur de virus a arn a brin negatif |
US7226786B2 (en) | 1999-05-18 | 2007-06-05 | Dnavec Research Inc. | Envelope gene-deficient Paramyxovirus vector |
KR100774796B1 (ko) * | 2000-01-19 | 2007-11-07 | 가부시키가이샤 디나벡크 겐큐쇼 | 파라믹소바이러스 벡터의 혈관으로의 유전자 도입용도 |
JPWO2001072340A1 (ja) | 2000-03-30 | 2004-01-08 | 株式会社ディナベック研究所 | センダイウイルスベクターを用いたaidsウイルスワクチン |
JP2002142770A (ja) | 2000-11-08 | 2002-05-21 | Dnavec Research Inc | 循環系への遺伝子送達用パラミクソウイルスベクター |
WO2002042481A1 (fr) | 2000-11-27 | 2002-05-30 | Dnavec Research Inc. | Vecteur paramyxovirus codant pour un gene d'angiogenese et son utilisation |
US8715922B2 (en) | 2001-01-19 | 2014-05-06 | ViroNovative | Virus causing respiratory tract illness in susceptible mammals |
UA93981C2 (ru) | 2001-01-19 | 2011-03-25 | Вироновативе Б.B. | Вирус, который вызывает заболевание дыхательных путей у чувствительных k этому млекопитающих |
FR2826010B1 (fr) * | 2001-06-14 | 2005-02-25 | Mahmood Salman Al | Oligonucleotides antisens capables d'inhiber la formation des tubes capillaires par les cellules endotheliales |
EP1437593A1 (de) * | 2001-09-18 | 2004-07-14 | Dnavec Research Inc. | Verfahren zur untersuchung von (-)-strang-rna-virusvektor mit verrringerter fähigkeit zur partikelbildung sowie verfahren zu seiner konstruktion |
CA2743750A1 (en) | 2002-02-21 | 2003-09-04 | Medimmune, Llc | Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from respiratory syncytial virus |
US7402427B2 (en) | 2002-04-30 | 2008-07-22 | Dnavec Research Inc. | Vectors with modified protease-dependent tropism |
KR100587388B1 (ko) * | 2003-02-14 | 2006-06-08 | 주식회사 효성 | 고강도 폴리비닐알코올 섬유의 제조방법 및 그로부터수득되는 고강도 폴리비닐알코올 섬유 |
KR20110097971A (ko) * | 2003-04-25 | 2011-08-31 | 메디뮨 백신즈, 인코포레이티드 | 메타뉴모바이러스 유래 이종 항원을 포함하는 재조합 파라인플루엔자 바이러스 발현 시스템 및 백신 |
EP1636371B1 (de) * | 2003-06-13 | 2012-04-25 | Apath, LLC | Replikon eines negativsträngigen rna-virus |
CN1902312B (zh) * | 2003-11-04 | 2011-02-23 | 株式会社载体研究所 | 制备导入了基因的树突细胞的方法 |
KR20060129013A (ko) | 2004-01-13 | 2006-12-14 | 가부시키가이샤 디나벡크 겐큐쇼 | 면역자극성 사이토카인을 코드하는 마이너스 가닥 rna 바이러스 벡터를 사용하는 종양의 유전자 치료 |
WO2005071085A1 (ja) * | 2004-01-22 | 2005-08-04 | Dnavec Research Inc. | ウイルスベクターの製造方法 |
JP4999330B2 (ja) | 2004-01-22 | 2012-08-15 | 株式会社ディナベック研究所 | サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖RNAウイルスベクターの製造方法 |
CN1957084A (zh) * | 2004-03-23 | 2007-05-02 | 株式会社载体研究所 | 与组织的维持和/或修复相关联的骨髓相关细胞 |
AU2005257105A1 (en) | 2004-06-24 | 2006-01-05 | Dnavec Research Inc. | Anticancer agent containing minus-strand RNA virus |
JP2008105946A (ja) * | 2005-02-08 | 2008-05-08 | Dnavec Corp | 遺伝子導入造血細胞から血液細胞を再構築させる方法 |
DE102005015005A1 (de) * | 2005-04-01 | 2006-10-05 | Qiagen Gmbh | Verfahren zur Behandlung einer Biomoleküle enthaltenden Probe |
CA2612168A1 (en) | 2005-06-14 | 2006-12-21 | Dnavec Corporation | Methods for producing antibodies |
WO2006137517A1 (ja) * | 2005-06-24 | 2006-12-28 | Dnavec Corporation | 幼少個体への遺伝子導入用ベクター |
JPWO2007049752A1 (ja) | 2005-10-28 | 2009-04-30 | ディナベック株式会社 | Rnaウイルスまたはdnaウイルスのスパイクタンパク質でシュードタイプ化したレンチウイルスベクターを用いた気道上皮幹細胞への遺伝子導入 |
EP1947181A4 (de) * | 2005-11-24 | 2010-09-22 | Genomidea Inc | Mutantes paramyxovirus und verfahren zur herstellung davon |
KR20080094910A (ko) * | 2006-01-17 | 2008-10-27 | 디나벡크 가부시키가이샤 | 신규 단백질 발현계 |
EP2034014A1 (de) | 2006-05-31 | 2009-03-11 | Dnavec Corporation | Therapeutikum gegen morbus alzheimer |
CN101517079A (zh) | 2006-07-13 | 2009-08-26 | 生物载体株式会社 | 非复制型副粘病毒科病毒载体 |
KR20090114431A (ko) | 2007-02-07 | 2009-11-03 | 디나벡크 가부시키가이샤 | 약독화 마이너스 가닥 rna 바이러스 |
JP4936482B2 (ja) * | 2007-04-13 | 2012-05-23 | 独立行政法人産業技術総合研究所 | 改良された持続感染型センダイウイルスベクター |
US20100203027A1 (en) | 2007-04-27 | 2010-08-12 | Kyushu Univeristy National University | Viral vector for gene therapy |
CN102159710B (zh) | 2008-07-16 | 2015-09-02 | 生物载体株式会社 | 使用染色体非整合型病毒载体制造经初始化的细胞的方法 |
US20120088819A1 (en) | 2008-10-31 | 2012-04-12 | Makoto Inoue | Method for enhancing expression of recombinant protein |
US8951801B2 (en) | 2009-02-27 | 2015-02-10 | Kyoto University | Method for making IPS cells |
JP5376478B2 (ja) | 2009-08-07 | 2013-12-25 | 国立大学法人京都大学 | 効率的な人工多能性幹細胞の樹立方法 |
US8993329B2 (en) | 2009-09-24 | 2015-03-31 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
WO2011052771A1 (ja) * | 2009-11-02 | 2011-05-05 | 国立大学法人三重大学 | パラミクソウイルスベクターを用いた経鼻噴霧型結核ワクチン |
WO2011083881A1 (ja) | 2010-01-08 | 2011-07-14 | 国立大学法人京都大学 | タウオパチー治療用ワクチン |
JP5827220B2 (ja) | 2010-01-22 | 2015-12-02 | 国立大学法人京都大学 | 人工多能性幹細胞の樹立効率改善方法 |
JP5856949B2 (ja) | 2010-04-16 | 2016-02-10 | 学校法人慶應義塾 | 人工多能性幹細胞の製造方法 |
JP5908838B2 (ja) * | 2010-08-30 | 2016-04-26 | 株式会社Idファーマ | 多能性幹細胞を誘導するための組成物およびその使用 |
EP2616540A4 (de) | 2010-09-14 | 2014-02-19 | Univ Kyoto | Verfahren zur effizienten herstellung induzierter pluripotenter stammzellen |
EP2631290A4 (de) | 2010-10-22 | 2015-06-10 | Univ Hokkaido Nat Univ Corp | Virusvektor für prime-boost-impfstoffe mit vacciniavirus-vektoren und sendaivirus-vektoren |
EP2647699B1 (de) | 2010-12-03 | 2020-04-01 | Kyoto University | Effizientes verfahren zur herstellung induzierter pluripotenter stammzellen |
JP5995237B2 (ja) | 2010-12-03 | 2016-09-21 | 国立大学法人京都大学 | 多能性幹細胞からの好酸球の製造方法 |
ES2640113T3 (es) * | 2011-02-08 | 2017-10-31 | Mie University | Método para producir un vector viral para la transferencia génica |
CN104968782B (zh) * | 2012-12-26 | 2019-09-06 | 生物科莫公司 | 利用人副流感2型病毒载体的疫苗 |
CN105916980A (zh) | 2013-09-24 | 2016-08-31 | 株式会社爱迪药业 | 用于改进诱导多能干细胞的效率的方法 |
US20180339038A1 (en) * | 2015-06-12 | 2018-11-29 | Mie University | Human parainfluenza virus type 2 vector and vaccine |
US11103574B2 (en) | 2016-11-17 | 2021-08-31 | Japan, as represented by the Director-General of National Institute of Infectious Disease | Infectious disease vaccine using non-infectious paramyxovirus particle |
CA3070552A1 (en) | 2017-07-21 | 2019-01-24 | I'rom Group Co., Ltd. | Polynucleotide for modifying target sequence and use thereof |
CN112135908A (zh) | 2018-01-22 | 2020-12-25 | 国立传染病研究所长代表日本国 | 选择性cd8阳性t细胞诱导疫苗抗原 |
WO2021138447A1 (en) | 2019-12-31 | 2021-07-08 | Elixirgen Therapeutics, Inc. | Temperature-based transient delivery of nucleic acids and proteins to cells and tissues |
US20230220025A1 (en) | 2020-09-04 | 2023-07-13 | Heartseed Inc. | Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells |
WO2022138964A1 (ja) | 2020-12-25 | 2022-06-30 | 国立大学法人京都大学 | 体細胞からのナイーブ型ヒトiPS細胞製造方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5512421A (en) * | 1991-02-19 | 1996-04-30 | The Regents Of The University Of California | Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
DK0864645T3 (da) * | 1995-10-31 | 2005-10-24 | Dnavec Research Inc | Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet |
JP3992200B2 (ja) * | 1995-11-01 | 2007-10-17 | 株式会社ディナベック研究所 | 組換え体センダイウイルスを利用した膜融合性リポソーム |
KR100525687B1 (ko) * | 1995-11-01 | 2005-11-25 | 가부시끼가이샤 디나벡 겡뀨쇼 | 재조합체 센다이바이러스 |
DE60039292D1 (de) * | 1999-05-18 | 2008-08-07 | Dnavec Research Inc | Ribonukleoproteinkomplex aus paramyxovirus |
-
2000
- 2000-05-18 AU AU46146/00A patent/AU4614600A/en not_active Abandoned
- 2000-05-18 JP JP2000618476A patent/JP3602058B2/ja not_active Expired - Lifetime
- 2000-05-18 KR KR1020017012612A patent/KR100739938B1/ko not_active IP Right Cessation
- 2000-05-18 CA CA2368948A patent/CA2368948C/en not_active Expired - Fee Related
- 2000-05-18 WO PCT/JP2000/003195 patent/WO2000070070A1/ja active IP Right Grant
- 2000-05-18 KR KR1020077008323A patent/KR20070058607A/ko not_active Application Discontinuation
- 2000-05-18 ES ES00927807T patent/ES2288473T3/es not_active Expired - Lifetime
- 2000-05-18 DK DK00927807T patent/DK1186667T3/da active
- 2000-05-18 CN CNB008056730A patent/CN1330767C/zh not_active Expired - Lifetime
- 2000-05-18 EP EP00927807A patent/EP1186667B1/de not_active Expired - Lifetime
- 2000-05-18 DE DE60035589T patent/DE60035589T2/de not_active Expired - Lifetime
- 2000-05-18 AT AT00927807T patent/ATE367445T1/de active
-
2002
- 2002-08-15 HK HK02105976A patent/HK1044352A1/xx not_active IP Right Cessation
-
2004
- 2004-08-02 JP JP2004253541A patent/JP2004329222A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2004329222A (ja) | 2004-11-25 |
KR20020014786A (ko) | 2002-02-25 |
CN1355851A (zh) | 2002-06-26 |
ES2288473T3 (es) | 2008-01-16 |
CA2368948C (en) | 2013-12-24 |
KR100739938B1 (ko) | 2007-07-16 |
EP1186667A4 (de) | 2004-06-30 |
JP3602058B2 (ja) | 2004-12-15 |
DE60035589T2 (de) | 2008-04-17 |
DK1186667T3 (da) | 2007-10-22 |
CN1330767C (zh) | 2007-08-08 |
AU4614600A (en) | 2000-12-05 |
WO2000070070A1 (fr) | 2000-11-23 |
CA2368948A1 (en) | 2000-11-23 |
EP1186667B1 (de) | 2007-07-18 |
KR20070058607A (ko) | 2007-06-08 |
HK1044352A1 (en) | 2002-10-18 |
DE60035589D1 (de) | 2007-08-30 |
EP1186667A1 (de) | 2002-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE367445T1 (de) | Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen | |
ES2288866T3 (es) | Paramixovirus que contienen una secuencia de inicio de la transcripcion modificada. | |
DE60033284D1 (de) | In vitro-rekonstitution von segmentierten, negativstrang-rna-viren | |
WO2003048348A3 (en) | Production of viruses, viral isolates and vaccines | |
WO2005062820A3 (en) | Multi plasmid system for the production of influenza virus | |
YU17891A (sh) | Dnk koja odgovara genomu virusa sa negativnim lancem rnk, i postupak za dobijanje infektivnih virusa sa negativnim lancem rnk | |
WO2003068923A3 (en) | Signal for packaging of influenza virus vectors | |
NZ503664A (en) | A method for purifying an RNA virus comprising generating a clonal virus and purifying the clonal virus by ultracentrifugation without pelleting | |
JP2006509523A5 (de) | ||
CY1106785T1 (el) | Ιικα σωματιδια τα οποια απελευθερωνονται μετα απο μολυνση απο ανθρωπινο κυτταρομεγαλοϊο και η χρηση τους ως εμβολιο | |
JP2006509524A5 (de) | ||
EP1757703A3 (de) | Self-inaktivierender Gammaretrovirenvektor | |
CA2368944A1 (en) | Paramyxovirus-derived rnp | |
JP2005523318A5 (de) | ||
WO2004055161A3 (en) | Large scale production of packaged alphavirus replicons | |
CY1107431T1 (el) | Σωματιδια για γoνιδιακη θεραπεια | |
WO2004000220A3 (en) | Methods for purifying viral particles for gene therapy | |
EP0213894A3 (de) | Defektive Viruspartikelimpfstoffe und Verfahren zur Anwendung derselben | |
BR0015740A (pt) | Mutações de faixa de hospedeiro de vìrus de membrana e seus usos como substratos de vacinas | |
WO2003029274A3 (en) | Paramyxoviruses as gene transfer vectors to lung cells | |
WO2001090302A3 (en) | Compositions and methods for production of rna viruses and rna virus-based vector particles | |
WO2002083896A3 (en) | Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same | |
WO2003057824A3 (en) | Compositions and methods for the inhibition of membrane fusion by paramyxoviruses | |
Heuss et al. | Crystallization of cowpea chlorotic mottle virus | |
Louboutin et al. | 446. Mokola Pseudotyped HIV V 446. Mokola Pseudotyped HIV Vector Expressing ector Expressing Dystrophin Can Protect mdx Mice from Exercise-Induced Necrosis of Muscle Fibers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1186667 Country of ref document: EP |